Researchers Highlight the Best Time for RSV Vaccine During Pregnancy Dr. Bhumika Maikhuri13 Nov 2024 8:30 AM ISTCurrent guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)-which typically causes mild, cold-like...
WHO Identifies 17 Top Priority Pathogens for New Vaccine Development Dr. Bhumika Maikhuri11 Nov 2024 8:15 AM ISTA new study by the World Health Organization (WHO) lists 17 bacteria, viruses and parasites that regularly cause disease as top priorities for new...
Maternal Antibodies May Interfere with Malaria Vaccine Responses: Study Finds Dr. Bhumika Maikhuri28 Oct 2024 8:45 AM ISTMaternal antibodies passed across the placenta can interfere with the response to the malaria vaccine, which would explain its lower efficacy in...
Maternal antibodies interfere with malaria vaccine responses, suggests study Dr. Kamal Kant Kohli25 Oct 2024 8:30 PM ISTMaternal antibodies passed across the placenta can interfere with the response to the malaria vaccine, which would explain its lower efficacy in...
Global Oral cholera vaccine stockpile empty, says WHO Kajal Rajput21 Oct 2024 6:15 PM ISTGeneva: There are no more oral cholera vaccines left in the global stockpile, the World Health Organization said Friday, with the shortage...
Approximately 80 Percent Protection May be Provided by RSV Vaccine Against Severe Disease and Death: Study Suggests Dr. Bhumika Maikhuri21 Oct 2024 8:15 AM ISTA multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the respiratory syncytial virus...
NIH Clinical Trial Shows Mpox Vaccine Safe for Adolescents Dr. Bhumika Maikhuri21 Oct 2024 7:45 AM ISTA National Institutes of Health (NIH)-funded clinical trial of an mpox vaccine in adolescents found it was safe and generated an antibody response...
Merck's RSV antibody Clesrovimab for infants shows 60.4% effectiveness in mid-to-late stage clinical trial MD Bureau19 Oct 2024 12:15 PM ISTThe drug clesrovimab also helped reduce RSV associated hospitalizations by 84.2% compared to placebo, Merck said.
Novavax faces setback as USFDA halts COVID-Flu vaccine trial over nerve damage report MD Bureau17 Oct 2024 3:13 PM ISTNovavax said a participant enrolled in a mid stage study of the combination vaccine last month reported symptoms of motor neuropathy.
GSK alleges patent infringement by Moderna in development of COVID19, RSV vaccines, files lawsuit MD Bureau16 Oct 2024 3:51 PM ISTLondon: British drugmaker GlaxoSmithKline (GSK) sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of violating...
This is just to create sensation: SC junks PIL alleging Covid vaccine side effects MD Bureau15 Oct 2024 3:15 PM IST"File a class action suit! What is the use of this? Please also understand what would be the side effect if you did not take the vaccine," SC added.
India's pharma industry sets global standard, saves billions for US healthcare, says Union Health Secretary MD Bureau15 Oct 2024 9:30 AM ISTThe medicines from Indian companies provided 219 billion USD savings to the US healthcare system in 2022.
